Atlas Trials

Effect of Albendazole Dose on Treatment of Lymphatic Filariasis

Clinical trial NCT00511004 · COMPLETED

Trial details

NCT number
NCT00511004
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphatic Filariasis
Start date
2007-07-01
Primary completion
2014-02-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.